CN Stock MarketDetailed Quotes

688488 Jiangsu Aidea Pharmaceutical

Watchlist
  • 10.22
  • +0.10+0.99%
Market Closed Jun 28 15:00 CST
4.30BMarket Cap-47757P/E (TTM)

Jiangsu Aidea Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-17.52%92.89M
68.44%411.36M
124.91%301.56M
223.59%238.74M
220.85%112.62M
-4.49%244.22M
-36.03%134.08M
-53.01%73.78M
-54.96%35.1M
-11.54%255.71M
Operating revenue
-17.52%92.89M
68.44%411.36M
124.91%301.56M
223.59%238.74M
220.85%112.62M
-4.49%244.22M
-36.03%134.08M
-53.01%73.78M
-54.96%35.1M
-11.54%255.71M
Total operating cost
2.21%120.44M
33.62%500.62M
45.36%357.79M
73.99%262.36M
75.35%117.84M
21.68%374.65M
9.96%246.14M
-4.67%150.79M
-7.76%67.2M
19.55%307.9M
Operating cost
-14.14%53.84M
58.73%221.34M
105.37%158.66M
167.13%124.18M
156.69%62.71M
-18.37%139.45M
-44.12%77.26M
-54.94%46.49M
-48.42%24.43M
18.42%170.84M
Operating tax surcharges
-50.04%919.25K
78.66%5.95M
96.29%4.84M
166.57%3.47M
197.31%1.84M
0.59%3.33M
-5.73%2.47M
-34.28%1.3M
-46.86%618.84K
-10.06%3.31M
Operating expense
16.00%21.19M
38.31%104.42M
48.81%73.38M
56.11%50.85M
90.20%18.27M
172.14%75.5M
192.23%49.31M
240.08%32.57M
126.89%9.6M
28.51%27.74M
Administration expense
-0.45%23.24M
3.48%95.28M
11.34%72.28M
20.07%50M
17.54%23.34M
52.20%92.07M
69.32%64.92M
64.69%41.64M
60.51%19.86M
0.58%60.49M
Financial expense
89.05%3.51M
2,525.42%10.46M
826.82%7.2M
436.02%4.12M
279.16%1.86M
118.48%398.35K
42.55%-991.23K
-11.70%-1.23M
-74.73%-1.04M
-238.93%-2.16M
-Interest expense (Financial expense)
97.15%3.9M
200.22%11.76M
250.35%8.21M
455.26%4.77M
1,830.75%1.98M
1,492.28%3.92M
3,696.09%2.34M
1,920.22%859.43K
469.50%102.36K
-91.62%246.09K
-Interest Income (Financial expense)
-48.74%-404.93K
45.36%-1.49M
56.27%-1M
64.36%-580.6K
69.20%-272.23K
-1.25%-2.72M
-20.45%-2.29M
-29.73%-1.63M
-47.10%-883.79K
-47.16%-2.69M
Research and development
80.58%17.75M
-1.13%63.18M
-22.12%41.41M
-0.90%29.74M
-28.40%9.83M
34.06%63.91M
80.44%53.18M
55.81%30.01M
64.99%13.73M
81.15%47.67M
Credit Impairment Loss
58.54%-1.52M
58.03%-3.73M
-161.40%-2.56M
-1,132.36%-5.68M
-626.45%-3.66M
-456.98%-8.89M
-132.34%-977.75K
-36.82%550.38K
7.36%696K
49.49%2.49M
Asset Impairment Loss
81.64%-46.98K
33.16%-23.67M
-191.50%-6.57M
-302.34%-7.15M
---255.91K
-237.53%-35.41M
-6,325.55%-2.25M
-5,012.92%-1.78M
----
-1,000.47%-10.49M
Other net revenue
Fair value change income
-31.64%3.11M
-84.35%1.54M
-64.09%3.95M
164.78%7.63M
3,253.94%4.55M
3,062.23%9.86M
2,333.18%10.99M
-1,331.61%-11.77M
-76.08%135.58K
-76.26%311.85K
Invest income
85.65%7.57M
81.60%12.62M
362.18%14.48M
398.68%10.68M
774.33%4.08M
-10.72%6.95M
-66.01%3.13M
-69.07%2.14M
-140.07%-605K
349.67%7.78M
-Including: Investment income associates
146.12%6.84M
860.42%6.81M
505.62%9.71M
441.43%7.84M
252.27%2.78M
79.33%-895.59K
-2,597.39%-2.39M
-275.15%-2.3M
-57.87%-1.83M
---4.33M
Asset deal income
----
125.64%70.41K
125.64%70.41K
121.00%69.34K
----
-98.02%31.2K
--31.2K
--31.38K
--31.2K
--1.58M
Other revenue
78.42%1.57M
-34.37%10.38M
36.54%6.63M
34.58%5.26M
-74.89%880.54K
136.69%15.82M
-24.03%4.85M
-9.19%3.91M
-13.50%3.51M
-53.19%6.68M
Operating profit
-4,684.01%-16.86M
35.21%-92.05M
58.22%-40.23M
84.73%-12.82M
101.30%367.81K
-224.10%-142.07M
-2,073.14%-96.29M
-803.92%-83.93M
-338.16%-28.34M
-188.47%-43.84M
Add:Non operating Income
-94.43%4.75K
0.42%140.2K
-11.34%103.79K
-16.25%93.59K
-14.35%85.4K
-96.57%139.62K
430.88%117.06K
1,012.79%111.76K
738.39%99.71K
3,448.93%4.07M
Less:Non operating expense
-67.03%27.95K
-60.62%177.29K
-56.40%138.08K
5,407.28%114.48K
107,525.66%84.77K
-82.06%450.16K
-80.78%316.73K
-97.83%2.08K
-98.09%78.76
1.17%2.51M
Total profit
-4,682.47%-16.88M
35.33%-92.09M
58.27%-40.27M
84.68%-12.84M
101.30%368.44K
-236.81%-142.38M
-3,065.01%-96.49M
-808.10%-83.82M
-337.17%-28.24M
-189.59%-42.27M
Less:Income tax cost
-2,683.38%-3.28M
12.44%-16.02M
59.94%-7.81M
79.27%-3.24M
98.02%-117.73K
-48.85%-18.29M
-475.75%-19.5M
-1,425.80%-15.63M
-1,127.21%-5.94M
-265.77%-12.29M
Add:Adjusted items effecting net profit
----
----
---0.01
----
----
----
----
----
----
----
Net profit
SL-13.61M
FPtoL-76.07M
FPtoL-32.46M
FPtoL-9.6M
FLtoP486.17K
FPtoL-124.09M
SL-76.99M
SL-68.19M
SL-22.3M
SL-29.99M
Net profit from continuing operation
-2,898.79%-13.61M
38.70%-76.07M
57.84%-32.46M
85.92%-9.6M
102.18%486.17K
-313.84%-124.09M
-1,259.39%-76.99M
-630.22%-68.19M
-296.87%-22.3M
-175.39%-29.99M
Net profit of parent company owners
-2,898.79%-13.61M
38.70%-76.07M
57.84%-32.46M
85.92%-9.6M
102.18%486.17K
-313.84%-124.09M
-1,259.39%-76.99M
-630.22%-68.19M
-296.87%-22.3M
-175.39%-29.99M
Earning per share
Basic earning per share
-2,600.00%-0.03
40.00%-0.18
55.56%-0.08
87.50%-0.02
102.40%0.0012
-328.57%-0.3
-1,000.00%-0.18
-633.33%-0.16
-266.67%-0.05
-170.00%-0.07
Diluted earning per share
-2,600.00%-0.03
40.00%-0.18
55.56%-0.08
87.50%-0.02
102.40%0.0012
-328.57%-0.3
-1,000.00%-0.18
-633.33%-0.16
-266.67%-0.05
-170.00%-0.07
Other composite income
-131.74%-302.15K
-134.22%-302.15K
-153.36%-255.75K
-534.29%-31.94K
1,004.50%951.98K
272.04%882.91K
170.25%479.24K
102.90%7.35K
138.33%86.19K
Other composite income of parent company owners
----
-131.74%-302.15K
-134.22%-302.15K
-153.36%-255.75K
-534.29%-31.94K
1,004.50%951.98K
272.04%882.91K
170.25%479.24K
102.90%7.35K
138.33%86.19K
Total composite income
-3,095.61%-13.61M
37.98%-76.37M
56.96%-32.76M
85.44%-9.86M
102.04%454.23K
-311.85%-123.14M
-1,342.09%-76.11M
-655.98%-67.71M
-301.31%-22.3M
-175.60%-29.9M
Total composite income of parent company owners
-3,095.61%-13.61M
37.98%-76.37M
56.96%-32.76M
85.44%-9.86M
102.04%454.23K
-311.85%-123.14M
-1,342.09%-76.11M
-655.98%-67.71M
-301.31%-22.3M
-175.60%-29.9M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
Notarized Tianye Certified Public Accountants (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -17.52%92.89M68.44%411.36M124.91%301.56M223.59%238.74M220.85%112.62M-4.49%244.22M-36.03%134.08M-53.01%73.78M-54.96%35.1M-11.54%255.71M
Operating revenue -17.52%92.89M68.44%411.36M124.91%301.56M223.59%238.74M220.85%112.62M-4.49%244.22M-36.03%134.08M-53.01%73.78M-54.96%35.1M-11.54%255.71M
Total operating cost 2.21%120.44M33.62%500.62M45.36%357.79M73.99%262.36M75.35%117.84M21.68%374.65M9.96%246.14M-4.67%150.79M-7.76%67.2M19.55%307.9M
Operating cost -14.14%53.84M58.73%221.34M105.37%158.66M167.13%124.18M156.69%62.71M-18.37%139.45M-44.12%77.26M-54.94%46.49M-48.42%24.43M18.42%170.84M
Operating tax surcharges -50.04%919.25K78.66%5.95M96.29%4.84M166.57%3.47M197.31%1.84M0.59%3.33M-5.73%2.47M-34.28%1.3M-46.86%618.84K-10.06%3.31M
Operating expense 16.00%21.19M38.31%104.42M48.81%73.38M56.11%50.85M90.20%18.27M172.14%75.5M192.23%49.31M240.08%32.57M126.89%9.6M28.51%27.74M
Administration expense -0.45%23.24M3.48%95.28M11.34%72.28M20.07%50M17.54%23.34M52.20%92.07M69.32%64.92M64.69%41.64M60.51%19.86M0.58%60.49M
Financial expense 89.05%3.51M2,525.42%10.46M826.82%7.2M436.02%4.12M279.16%1.86M118.48%398.35K42.55%-991.23K-11.70%-1.23M-74.73%-1.04M-238.93%-2.16M
-Interest expense (Financial expense) 97.15%3.9M200.22%11.76M250.35%8.21M455.26%4.77M1,830.75%1.98M1,492.28%3.92M3,696.09%2.34M1,920.22%859.43K469.50%102.36K-91.62%246.09K
-Interest Income (Financial expense) -48.74%-404.93K45.36%-1.49M56.27%-1M64.36%-580.6K69.20%-272.23K-1.25%-2.72M-20.45%-2.29M-29.73%-1.63M-47.10%-883.79K-47.16%-2.69M
Research and development 80.58%17.75M-1.13%63.18M-22.12%41.41M-0.90%29.74M-28.40%9.83M34.06%63.91M80.44%53.18M55.81%30.01M64.99%13.73M81.15%47.67M
Credit Impairment Loss 58.54%-1.52M58.03%-3.73M-161.40%-2.56M-1,132.36%-5.68M-626.45%-3.66M-456.98%-8.89M-132.34%-977.75K-36.82%550.38K7.36%696K49.49%2.49M
Asset Impairment Loss 81.64%-46.98K33.16%-23.67M-191.50%-6.57M-302.34%-7.15M---255.91K-237.53%-35.41M-6,325.55%-2.25M-5,012.92%-1.78M-----1,000.47%-10.49M
Other net revenue
Fair value change income -31.64%3.11M-84.35%1.54M-64.09%3.95M164.78%7.63M3,253.94%4.55M3,062.23%9.86M2,333.18%10.99M-1,331.61%-11.77M-76.08%135.58K-76.26%311.85K
Invest income 85.65%7.57M81.60%12.62M362.18%14.48M398.68%10.68M774.33%4.08M-10.72%6.95M-66.01%3.13M-69.07%2.14M-140.07%-605K349.67%7.78M
-Including: Investment income associates 146.12%6.84M860.42%6.81M505.62%9.71M441.43%7.84M252.27%2.78M79.33%-895.59K-2,597.39%-2.39M-275.15%-2.3M-57.87%-1.83M---4.33M
Asset deal income ----125.64%70.41K125.64%70.41K121.00%69.34K-----98.02%31.2K--31.2K--31.38K--31.2K--1.58M
Other revenue 78.42%1.57M-34.37%10.38M36.54%6.63M34.58%5.26M-74.89%880.54K136.69%15.82M-24.03%4.85M-9.19%3.91M-13.50%3.51M-53.19%6.68M
Operating profit -4,684.01%-16.86M35.21%-92.05M58.22%-40.23M84.73%-12.82M101.30%367.81K-224.10%-142.07M-2,073.14%-96.29M-803.92%-83.93M-338.16%-28.34M-188.47%-43.84M
Add:Non operating Income -94.43%4.75K0.42%140.2K-11.34%103.79K-16.25%93.59K-14.35%85.4K-96.57%139.62K430.88%117.06K1,012.79%111.76K738.39%99.71K3,448.93%4.07M
Less:Non operating expense -67.03%27.95K-60.62%177.29K-56.40%138.08K5,407.28%114.48K107,525.66%84.77K-82.06%450.16K-80.78%316.73K-97.83%2.08K-98.09%78.761.17%2.51M
Total profit -4,682.47%-16.88M35.33%-92.09M58.27%-40.27M84.68%-12.84M101.30%368.44K-236.81%-142.38M-3,065.01%-96.49M-808.10%-83.82M-337.17%-28.24M-189.59%-42.27M
Less:Income tax cost -2,683.38%-3.28M12.44%-16.02M59.94%-7.81M79.27%-3.24M98.02%-117.73K-48.85%-18.29M-475.75%-19.5M-1,425.80%-15.63M-1,127.21%-5.94M-265.77%-12.29M
Add:Adjusted items effecting net profit -----------0.01----------------------------
Net profit SL-13.61MFPtoL-76.07MFPtoL-32.46MFPtoL-9.6MFLtoP486.17KFPtoL-124.09MSL-76.99MSL-68.19MSL-22.3MSL-29.99M
Net profit from continuing operation -2,898.79%-13.61M38.70%-76.07M57.84%-32.46M85.92%-9.6M102.18%486.17K-313.84%-124.09M-1,259.39%-76.99M-630.22%-68.19M-296.87%-22.3M-175.39%-29.99M
Net profit of parent company owners -2,898.79%-13.61M38.70%-76.07M57.84%-32.46M85.92%-9.6M102.18%486.17K-313.84%-124.09M-1,259.39%-76.99M-630.22%-68.19M-296.87%-22.3M-175.39%-29.99M
Earning per share
Basic earning per share -2,600.00%-0.0340.00%-0.1855.56%-0.0887.50%-0.02102.40%0.0012-328.57%-0.3-1,000.00%-0.18-633.33%-0.16-266.67%-0.05-170.00%-0.07
Diluted earning per share -2,600.00%-0.0340.00%-0.1855.56%-0.0887.50%-0.02102.40%0.0012-328.57%-0.3-1,000.00%-0.18-633.33%-0.16-266.67%-0.05-170.00%-0.07
Other composite income -131.74%-302.15K-134.22%-302.15K-153.36%-255.75K-534.29%-31.94K1,004.50%951.98K272.04%882.91K170.25%479.24K102.90%7.35K138.33%86.19K
Other composite income of parent company owners -----131.74%-302.15K-134.22%-302.15K-153.36%-255.75K-534.29%-31.94K1,004.50%951.98K272.04%882.91K170.25%479.24K102.90%7.35K138.33%86.19K
Total composite income -3,095.61%-13.61M37.98%-76.37M56.96%-32.76M85.44%-9.86M102.04%454.23K-311.85%-123.14M-1,342.09%-76.11M-655.98%-67.71M-301.31%-22.3M-175.60%-29.9M
Total composite income of parent company owners -3,095.61%-13.61M37.98%-76.37M56.96%-32.76M85.44%-9.86M102.04%454.23K-311.85%-123.14M-1,342.09%-76.11M-655.98%-67.71M-301.31%-22.3M-175.60%-29.9M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion--------
Auditor --Notarized Tianye Certified Public Accountants (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg